Literature DB >> 7238271

Intraperitoneal coagulation in chronic liver disease ascites.

J Hoefs, T Barnes, P Halle.   

Abstract

Twenty patients with the ascites of chronic liver disease were investigated for in vivo evidence of active coagulation within ascites by detection of fibrin monomer. Increased levels of fibrin monomer, increased fibrin/fibrinogen degradation products, and absent or low levels of fibrinogen in the ascites of all patients tested confirmed the presence of intraperitoneal coagulation when ascites is present.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7238271     DOI： 10.1007/bf01308100

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Intravascular coagulation and the liver.

Authors:  A L Bloom
Journal:  Br J Haematol       Date:  1975-05       Impact factor: 6.998

2.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

3.  Theory and experience behind the use of coagulation tests in diagnosis and prognosis of liver disease.

Authors:  F Koller
Journal:  Scand J Gastroenterol Suppl       Date:  1973

4.  The diagnostic value of coagulation studies in chronic liver disease.

Authors:  J J Veltkamp; J Kreuning
Journal:  Scand J Gastroenterol Suppl       Date:  1973

5.  Detection of intravascular coagulation by a serial-dilution protamine sulfate test.

Authors:  V Gurewich; E Hutchinson
Journal:  Ann Intern Med       Date:  1971-12       Impact factor: 25.391

6.  Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites.

Authors:  J D Ansley; R A Bethel; P A Bowen; W D Warren
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

7.  A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.

Authors:  S M Ratky; M J Martin; Y B Gordon; L R Baker; T Chard; J Leslie
Journal:  Br J Haematol       Date:  1975-06       Impact factor: 6.998

8.  Refractory coagulopathy in an infant with loss of clotting proteins into ascitic fluid.

Authors:  C A Johnson; T C Sobrinho; E M Aziz; S B Rogers
Journal:  Acta Paediatr Scand       Date:  1976-11

9.  Disseminated intravascular coagulation with the peritoneovenous shunt.

Authors:  D C Harmon; Z Demirjian; L Ellman; J E Fischer
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

10.  Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.

Authors:  J P Villeneuve; C Thuot; D Marleau; J G Joly; P M Huet; A Viallet
Journal:  Can Med Assoc J       Date:  1977-12-03       Impact factor: 8.262
View more
  2 in total

1.  Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations.

Authors:  M M Stanley; C V Reyes; H B Greenlee; B Nemchausky; G F Reinhardt
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

2.  Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.

Authors:  H H Salem; F J Dudley; A Merrett; J Perkin; B G Firkin
Journal:  Gut       Date:  1983-05       Impact factor: 23.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.